The nation of Zimbabwe has turned down a major American healthcare agreement valued at $367m (£272m) over five years due to Washington's insistence on sensitive data.
This move became public after a internal memorandum from December was leaked, which showed Head of State Emmerson Mnangagwa deemed the deal was "skewed".
A government spokesperson has since clarified that the US was requesting genetic material for scientific study and commercial purposes but was unwilling to guarantee the benefits from any future treatments.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for more talks to reach a deal agreeable to both sides so the nation's critical HIV treatment initiative can be sustained.
Broader Context
This development follows a comparable situation in Kenya, where a high court suspended a similar health funding agreement following legal challenges were filed about the safety of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump claimed its expenditure was "inefficient" and his government was seeking government-to-government agreements to enhance transparency and responsibility.
Based on reports, 16 nations in Africa have so far signed these new agreements, constituting over $18.3bn in new funding.
Specifics of the Declined Agreement
The money for Zimbabwe would have funded "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this partnership could have provided immense benefits for the people of Zimbabwe, especially the 1.2 million currently receiving antiretroviral therapy via US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to provide its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our country would supply the raw materials for scientific discovery with no certainty that the end products would be available to our population if a future disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral deals were undermining structures previously set up via the global health agency.
The spokesperson cited its Pandemic Benefit-Sharing scheme designed to deal with future pandemics.
"This framework is designed to ensure that when a country contributes its data, the resulting advantages – including medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."
These objections over the US deal "are not meant as anti-American sentiment," he added.
"We are open to further discussions with our American counterparts on how future co-operation might be designed in a way that respects the independence and dignity of both nations."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but urged that negotiations need to persist given that much of the country's Aids initiatives were funded by foreign aid.
"Where specific concerns exist, such as those involving information security or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," the group commented.
The halted deal emphasises the complex tensions between accepting crucial foreign assistance and safeguarding national sovereignty in an ever more interconnected world.